Clinical Trials Directory

Trials / Unknown

UnknownNCT04197167

Mid-Infrared Spectroscopy as a Real Time Diagnostic Tool for Chronic Endometritis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The Investigator propose to develop an in-vitro technique for the measurement and analysis of freshly excised biopsies during hysteroscopy procedure in patients with suspected Chronic Endometritis (CE) condition. Furthermore, the investigator propose to develop a discrimination model between the CE and inflammatory CE types using the measured spectroscopic data from freshly excised biopsies.

Detailed description

It is common practice that, following hysteroscopy, the clinician needs to wait for about two weeks before the results of the histology are returned and the clinical treatment is initiated. In this research, the investigator intent to show that the mid infrared ATR (Assisted Reproductive Treatment) spectroscopy method will provide the physician with sufficient information about the CE inflammation status in a considerably shorter period of time to allow immediate initiation of the appropriate treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREHysteroscopyDiagnostic procedure
DEVICEInfrared SpectroscopyThis device uses spectral absorption of the tissue taken during hysteroscopy to determine immediate diagnosis of Chronic Endometritis

Timeline

Start date
2019-12-12
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2019-12-12
Last updated
2022-06-23

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04197167. Inclusion in this directory is not an endorsement.